Diagnostics (TB)

CDC Planning Cost Evaluation for NAA Testing

Published in TB and Outbreaks Week, June 2nd, 1997

Studies evaluating the cost-effectiveness and operating characteristics of nucleic acid amplification tests when used in the diagnosis of tuberculosis are planned by the U.S. Centers for Disease Control and Prevention (CDC).

The CDC's Research and Evaluation Program (REB) plans to issue a request for contracts for the nucleic acid amplification (NAA) tests. In addition, sera from the studies will be contributed to a diagnostic specimen bank at the CDC to facilitate the evaluation of other new tests which might be developed in the future.

Recently, two new rapid tests for the diagnosis of TB based on the amplification of mycobacterial nucleic acid,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1997-06-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry